重新思考MYC抑制:一种多维的方法来克服癌症的主调节器
Jing Yu1, Dan Liu1, Yujian Yuan2
1Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, Municipal Hospital, Qingdao, China.
Frontiers in cell and developmental biology
|May 14, 2025
概括
以前被认为是无毒的MYC瘤蛋白现在被新型抑制剂和降解剂所准,为MYC驱动的癌症提供了新的希望. 组合疗法和以生物标志物为指导的策略是克服挑战和改善患者结果的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 这种MYC蛋白质是癌症发展的关键调节者.
- 在历史上,MYC的混乱结构使其成为一个具有挑战性的治疗目标.
- 最近的突破正在使MYC的直接准成为可能.
研究的目的:
- 审查针对MYCcoprotein的最新进展.
- 讨论新兴的治疗策略及其临床潜力.
- 倡导一个全面的方法来MYC向癌症治疗.
主要方法:
- 对直接MYC抑制剂 (例如Omomyc) 的审查.
- 基于PROTAC的MYC降解剂 (例如WBC100) 的分析.
- 探索包括BET/CDK9抑制剂,RNA疗法,纳米体和工程蛋白酶在内的互补策略.
主要成果:
- 直接MYC抑制剂和PROTAC降解剂显示出有前途的临床进展.
- 不同的治疗方式正在扩大MYC向的范围.
- 与化疗,放射疗法或免疫疗法的联合疗法具有协同效应.
结论:
- MYC正在成为瘤学中可用药物的目标.
- 关于特异性,毒性和传递的挑战仍然存在,但正在解决.
- 具有合理药物组合的多维,生物标志物引导的方法对于有效的MYC驱动的癌症治疗至关重要.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


